U.S. markets closed

Cybeats Technologies Corp (P4T.MU)

Munich - Munich Delayed Price. Currency in EUR
0.9580-0.0400 (-4.01%)
At close: 01:50PM CET
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.9980
Bid0.9640 x N/A
Ask1.0150 x N/A
Day's Range0.9480 - 0.9580
52 Week Range0.8960 - 1.1560
Avg. Volume1,148
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for P4T.MU

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Newsfile

      Cybeats Announces 75% of SBOM Studio Pilot Evaluations Have Converted into Commercial Contracts

      Toronto, Ontario--(Newsfile Corp. - January 27, 2023) - Cybeats Technologies Corp. (CSE: CYBT) ("Cybeats'' or the "Company") is pleased to report that after the signing of recent commercial contracts, 75% of all organizations that have completed SBOM Studio1 pilot evaluation periods have moved on to sign commercial licence agreements with the Company.SBOM Studio is defining and pioneering the future of automated SBOM management, helping organizations proactively improve visibility and security a

    • CNW Group

      Cybeats Signs Three-Year Commercial Agreement with Fortune 500 Building Technology and Industrial Automation Company

      Cybeats Technologies Corp. ("Cybeats'' or the "Company") (CSE: CYBT) is pleased to announce the signing of a three-year software licence agreement for Cybeats SBOM Studio1 with a global leader in building technology and industrial automation, to manage their Software Bill of Materials (SBOM) and improve security across the software supply chain.

    • CNW Group

      Cybeats Signs Commercial Agreement with a Top 3 Global Medical Device and Diagnostics Company

      Cybeats Technologies Corp. ("Cybeats'' or the "Company") (CSE: CYBT) is pleased to announce a new software licence agreement with a top 3 global medical device and diagnostics leader, for Cybeats' SBOM Studio1, to manage their Software Bill of Materials (SBOM) and support regulatory compliance requirements with looming FDA mandates on SBOM adoption for medical device manufacturers.2